Bath & Body Works’ (BBWI) Outperform Rating Reaffirmed at Raymond James

Bath & Body Works (NYSE:BBWI)‘s stock had its “outperform” rating reissued by equities researchers at Raymond James in a report issued on Tuesday,Benzinga reports. They presently have a $46.00 price target on the stock, up from their previous price target of $42.00. Raymond James’ price objective indicates a potential upside of 15.30% from the stock’s current price.

A number of other research firms have also recently weighed in on BBWI. TD Cowen upped their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Argus restated a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. JPMorgan Chase & Co. upgraded Bath & Body Works from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $41.00 to $47.00 in a research note on Tuesday, February 18th. Wells Fargo & Company raised Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Six research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, Bath & Body Works currently has an average rating of “Moderate Buy” and an average target price of $44.44.

Bath & Body Works Trading Up 0.1 %

BBWI traded up $0.03 during midday trading on Tuesday, reaching $39.90. The company’s stock had a trading volume of 1,027,000 shares, compared to its average volume of 3,281,653. The company has a fifty day simple moving average of $37.73 and a 200 day simple moving average of $33.96. The stock has a market cap of $8.64 billion, a P/E ratio of 9.72, a PEG ratio of 0.92 and a beta of 1.83. Bath & Body Works has a twelve month low of $26.20 and a twelve month high of $52.99.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.03. The company had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period last year, the business posted $0.48 EPS. Sell-side analysts expect that Bath & Body Works will post 3.3 earnings per share for the current year.

Hedge Funds Weigh In On Bath & Body Works

A number of hedge funds and other institutional investors have recently bought and sold shares of BBWI. SRS Capital Advisors Inc. boosted its stake in shares of Bath & Body Works by 99.7% during the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after acquiring an additional 329 shares during the period. Golden State Wealth Management LLC bought a new position in Bath & Body Works during the fourth quarter worth $26,000. UMB Bank n.a. lifted its stake in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after buying an additional 335 shares during the last quarter. Lindbrook Capital LLC boosted its holdings in shares of Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after buying an additional 431 shares during the period. Finally, Smartleaf Asset Management LLC grew its stake in Bath & Body Works by 135.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company’s stock valued at $39,000 after buying an additional 582 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.